Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

20drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: VEM+COBI ×

VEM+COBI

This drug is selected. Its supporting articles are shown below.

Articles mentioning VEM+COBI

2 articles · page 1 of 1

Efficacy of nivolumab plus relatlimab versus BRAF/MEK inhibitors for first-line treatment of BRAF-mutant advanced melanoma: A matching-adjusted indirect comparison

bmjonc · full text · 2025-12-14 · 16 matching annotations

87.5%

encorafenib vemurafenib binimetinib cobimetinib dabrafenib NIVO+RELA atezolizumab nivolumab trametinib NIVO+IPI

…TEZO, atezolizumab; BINI, binimetinib; COBI, cobimetinib; ENCO, encorafenib; ESS, effective sample size; DAB, dabrafenib; NIVO, nivolumab; …

Efficacy of nivolumab plus relatlimab versus BRAF/MEK inhibitors for first-line treatment of BRAF-mutant advanced melanoma: A matching-adjusted indirect comparison

bmjonc · abstract · 2025-12-14 · 4 matching annotations

82.0%

dabrafenib atezolizumab cobimetinib binimetinib trametinib nivolumab vemurafenib encorafenib relatlimab ENCO+BINI+3 more

…(NIVO+RELA) to BRAF/MEK inhibitors, we compared its efficacy to dabrafenib+trametinib (DAB+TRAM), encorafenib+binimetinib (ENCO+BINI), vem…